PMID- 22851861 OWN - NLM STAT- MEDLINE DCOM- 20130110 LR - 20211021 IS - 2219-2840 (Electronic) IS - 1007-9327 (Print) IS - 1007-9327 (Linking) VI - 18 IP - 28 DP - 2012 Jul 28 TI - Lentiviral vector-mediated down-regulation of IL-17A receptor in hepatic stellate cells results in decreased secretion of IL-6. PG - 3696-704 LID - 10.3748/wjg.v18.i28.3696 [doi] AB - AIM: To investigate the mechanism of interleukin (IL)-6 secretion through blocking the IL-17A/IL-17A receptor (IL-17RA) signaling pathway with a short hairpin RNA (shRNA) in hepatic stellate cells (HSCs) in vitro. METHODS: HSCs were derived from the livers of adult male Sprague-Dawley rats. IL-6 expression was evaluated using real-time quantitative polymerase chain reaction and enzyme linked immunosorbent assay. The phosphorylation activity of p38 mitogen activated protein kinases (MAPK) and extracellular regulated protein kinases (ERK) 1/2 upon induction by IL-17A and suppression by IL-17RA shRNA were examined using Western blotting. RESULTS: IL-6 expression induced by IL-17A was significantly increased compared to control in HSCs (P < 0.01 in a dose-dependent manner). Suppression of IL-17RA using lentiviral-mediated shRNA inhibited IL-6 expression induced by IL-17A compared to group with only IL-17A treatment (1.44 +/- 0.17 vs 4.07 +/- 0.43, P < 0.01). IL-17A induced rapid phosphorylation of p38 MAPK and ERK1/2 after 5 min exposure, and showed the strongest levels of phosphorylation of p38 MAPK and ERK1/2 at 15 min in IL-17A-treated HSCs. IL-6 mRNA expression induced by IL-17A (100 ng/mL) for 3 h exposure was inhibited by preincubation with specific inhibitors of p38 MAPK (SB-203580) and ERK1/2 (PD-98059) compared to groups without inhibitors preincubation (1.67 +/- 0.24, 2.01 +/- 0.10 vs 4.08 +/- 0.59, P < 0.01). Moreover, Lentiviral-mediated IL-17RA shRNA 1 inhibited IL-17A-induced IL-6 mRNA expression compared to random shRNA in HSCs (1.44 +/- 0.17 vs 3.98 +/- 0.68, P < 0.01). Lentiviral-mediated IL-17RA shRNA 1 inhibited phosphorylation of p38 MAPK and ERK1/2 induced by 15 min IL-17A (100 ng/mL) exposure. CONCLUSION: Down-regulation of the IL-17RA receptor by shRNA decreased IL-6 expression induced by IL-17A via p38 MAPK and ERK1/2 phosphorylation in HSCs. Suppression of IL-17RA expression may be a strategy to reduce the inflammatory response induced by IL-17A in the liver. FAU - Zhang, Sheng-Chu AU - Zhang SC AD - Department of General Surgery, The First Affiliated Hospital of Wenzhou Medical College, Wenzhou 325000, Zhejiang Province, China. FAU - Zheng, Yi-Hu AU - Zheng YH FAU - Yu, Pan-Pan AU - Yu PP FAU - Min, Tan Hooi AU - Min TH FAU - Yu, Fu-Xiang AU - Yu FX FAU - Ye, Chao AU - Ye C FAU - Xie, Yuan-Kang AU - Xie YK FAU - Zhang, Qi-Yu AU - Zhang QY LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - World J Gastroenterol JT - World journal of gastroenterology JID - 100883448 RN - 0 (Enzyme Inhibitors) RN - 0 (Interleukin-6) RN - 0 (RNA, Small Interfering) RN - 0 (Receptors, Interleukin-17) RN - EC 2.7.11.24 (Mapk1 protein, rat) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinase 1) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinase 3) RN - EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases) SB - IM MH - Animals MH - Base Sequence MH - Dose-Response Relationship, Drug MH - Enzyme Inhibitors/pharmacology MH - *Gene Expression Regulation MH - Genetic Vectors MH - Hepatic Stellate Cells/*cytology MH - Inflammation MH - Interleukin-6/*metabolism MH - Lentivirus/*genetics MH - Liver Cirrhosis/pathology MH - Male MH - Mitogen-Activated Protein Kinase 1/metabolism MH - Mitogen-Activated Protein Kinase 3/metabolism MH - Molecular Sequence Data MH - Phosphorylation MH - Plasmids/metabolism MH - RNA, Small Interfering/metabolism MH - Rats MH - Rats, Sprague-Dawley MH - Receptors, Interleukin-17/*metabolism MH - Signal Transduction MH - p38 Mitogen-Activated Protein Kinases/metabolism PMC - PMC3406421 OTO - NOTNLM OT - Hepatic stellate cells OT - Interleukin 17A OT - Interleukin 6 OT - Liver fibrosis EDAT- 2012/08/02 06:00 MHDA- 2013/01/11 06:00 PMCR- 2012/07/28 CRDT- 2012/08/02 06:00 PHST- 2011/10/05 00:00 [received] PHST- 2012/04/04 00:00 [revised] PHST- 2012/05/06 00:00 [accepted] PHST- 2012/08/02 06:00 [entrez] PHST- 2012/08/02 06:00 [pubmed] PHST- 2013/01/11 06:00 [medline] PHST- 2012/07/28 00:00 [pmc-release] AID - 10.3748/wjg.v18.i28.3696 [doi] PST - ppublish SO - World J Gastroenterol. 2012 Jul 28;18(28):3696-704. doi: 10.3748/wjg.v18.i28.3696.